In 1999, the Institute of Medicine reported “a potential therapeutic value for cannabinoid
drugs,” particularly for pain relief, control of nausea and appetite stimulation (http://books …

Science Base, said advances in cannabinoid science over the last 16 years offer
opportunities for the development of medical marijuana. The report summarizes and …

There is a pressing need to develop new medications for many debilitating conditions. Novel
approaches based on marijuana or its constituent cannabinoids, if proven, could be added …

Therapeutics explains, there is little incentive for the pharmaceutical industry to study the
naturally occurring cannabinoids found in smoked marijuana, like that produced by the …

Approximately 156 million Americans (49% of the population) have tried cannabis.(1) About
5.7 million people ages 12 years and older use it daily or almost daily, a number that has …

In an article in this issue of the Journal, Hasin and colleagues (1) used data from the
National Epidemiologic Survey on Alcohol and Related Conditions to examine differences in …

Marijuana has been an illegal drug since the Marihuana Tax Act of 1937, which classified it
as a narcotic on par with heroin and cocaine. During the 1950s, marijuana was included in a …

SCIENTISTS INTERESTED in filling in the therapeutic blanks about medicinal marijuana
hope a new nonpartisan report will expedite applications for federal funds and supplies of …

Revised regulations governing Health Canada's medicinal marijuana program reduce the
onus on physicians as gatekeepers, but the 4-year-old program is still cause for concern …

In response to public pressure to allow the medical use of marijuana, the Office of National
Drug Control Policy, Washington, DC, funded a study by the Institute of Medicine evaluating …